CoChat

Long‐term clinical outcomes following treatment of childhood craniopharyngioma

Open access
Winkfield, Karen M., Tsai, Henry K., Yao, Xiaopan, Larson, Elysia, Neuberg, Donna, Pomeroy, Scott L., Ullrich, Nicole J., Cohen, Laurie E., Kieran, Mark W., Scott, R. Michael, Goumnerova, Liliana C., Marcus, Karen J. · 2011 · Pediatric Blood & Cancer
Cited by 69

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Purpose: To review our institution's experience with treatment of craniopharyngioma in children, and to report long‐term treatment outcomes stratified by treatment era to assess whether modern treatment techniques result in improvements in local control and survival. Materials and Methods: We retrospectively reviewed the records of 100 children who underwent surgery for craniopharygioma at Children's Hospital Boston (CHB) from August 1976 to March 2003. Of these, 79 children (median age 8.5 years) had initial treatment at CHB and sufficient follow‐up data to be included in this analysis. We report their treatment course, recurrence rates, and treatment‐related morbidity. We compared the results in two different treatment eras based on changes in surgical approach at CHB. Results: Thirty‐six patients underwent initial treatment with surgery alone; 63% treated prior to 1988 recurred and 36% treated after 1988 recurred. Recurrence rates following combined modality therapy (CMT) with limited surgery followed by radiation were 21 and 5% in the pre‐ and post‐1988 eras, respectively. Accounting for treatment era, patients treated with surgery alone were 7.7 times as likely to recur as those treated with CMT (95%CI: 2.0, 28.7). In the Cox regression model, there was no significant difference in local control or overall survival based on treatment era; initial treatment remained the only statistically significant variable (P = 0.02). Conclusions: Advancements in treatment techniques have improved local control in children diagnosed with craniopharyngioma. The excellent survival rates necessitate long‐term patient follow‐up to identify and manage any treatment‐related effects, including second tumors, vascular abnormalities, and endocrinopathies. Pediatr Blood Cancer 2011;56:1120–1126. © 2010 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pbc.22884

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Metadata

Authors
Winkfield, K. M., Tsai, H. K., Yao, X., Larson, E., Neuberg, D., Pomeroy, S. L., Ullrich, N. J., Cohen, L. E., Kieran, M. W., Scott, R. M., Goumnerova, L. C., & Marcus, K. J.
Venue
Pediatric Blood & Cancer
Publisher
Wiley
Published
2010-12
Volume
56
Issue
7
Pages
1120-1126
ISSN
  • 1545-5009 (ISSN-L)
  • 1545-5017
OpenAlex
W2061364494
Cited by
69
References
1
FWCI
3.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long‐term clinical outcomes following treatment of childhood craniopharyngioma. https://app.cochat.ai/papers/10.1002/pbc.22884
The paper
Winkfield, K. M., Tsai, H. K., Yao, X., Larson, E., Neuberg, D., Pomeroy, S. L., Ullrich, N. J., Cohen, L. E., Kieran, M. W., Scott, R. M., Goumnerova, L. C., & Marcus, K. J. (2011). Long‐term clinical outcomes following treatment of childhood craniopharyngioma. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.22884

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.